Gene · 4598
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deficiency of Adenosine Deaminase 2 Presenting as Periodic Fever at the Mainland of Familial Mediterranean Fever. | J Clin Immunol | 2022 | 35804211 | PubTator, text mining | PubMed |
| Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets. | Front Cell Dev Biol | 2022 | 35800898 | PubTator, text mining | PubMed |
| Genetic dissection of non-syndromic retinitis pigmentosa. | Indian J Ophthalmol | 2022 | 35791117 | PubTator, text mining | PubMed |
| Approach to inherited retinal diseases. | Indian J Ophthalmol | 2022 | 35791111 | PubTator, text mining | PubMed |
| Lipid metabolism in tumor microenvironment: novel therapeutic targets. | Cancer Cell Int | 2022 | 35790992 | PubTator, text mining | PubMed |
Mevalonate kinase deficiency/Hyperimmunoglobulin D syndrome (MVK/HIDS) in a Differential Diagnosis of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Familial Mediterranean Fever (FMF): A Case Report. | Turk Arch Pediatr | 2022 | 35781244 | PubTator, text mining | PubMed |
Combined Analysis of Pharmaceutical Active Ingredients and Transcriptomes of Glycyrrhiza uralensis Under PEG6000-Induced Drought Stress Revealed Glycyrrhizic Acid and Flavonoids Accumulation via JA-Mediated Signaling. | Front Plant Sci | 2022 | 35769299 | PubTator, text mining | PubMed |
| Multi-block data integration analysis for identifying and validating targeted N-glycans as biomarkers for type II diabetes mellitus. | Sci Rep | 2022 | 35768493 | PubTator, text mining | PubMed |
| Using a scenario approach to assess for the current and future demand of immunoglobulins: An interview and literature study from The Netherlands. | Transfus Med | 2022 | 35751376 | PubTator, text mining | PubMed |
| Lipid Metabolism and Cancer. | Life (Basel) | 2022 | 35743814 | PubTator, text mining | PubMed |
| The Spike Protein of SARS-CoV-2 Impairs Lipid Metabolism and Increases Susceptibility to Lipotoxicity: Implication for a Role of Nrf2. | Cells | 2022 | 35741045 | PubTator, text mining | PubMed |
| A method for the inference of cytokine interaction networks. | PLoS Comput Biol | 2022 | 35731827 | PubTator, text mining | PubMed |
| IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting. | Nat Rev Rheumatol | 2022 | 35729334 | PubTator, text mining | PubMed |
| NLRP3-Dependent Pyroptosis: A Candidate Therapeutic Target for Depression. | Front Cell Neurosci | 2022 | 35722622 | PubTator, text mining | PubMed |
| Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases. | Front Immunol | 2022 | 35720358 | PubTator, text mining | PubMed |
| Twists and turns of the genetic story of mevalonate kinase-associated diseases: A review. | Genes Dis | 2022 | 35685471 | PubTator, text mining | PubMed |
| Risk assessment with gut microbiome and metabolite markers in NAFLD development. | Sci Transl Med | 2022 | 35675435 | PubTator, text mining | PubMed |
| A preliminary study of peripheral T-cell subsets in porokeratosis patients with MVK or MVD variants. | Skin Health Dis | 2022 | 35665211 | PubTator, text mining | PubMed |
| Mixed porokeratosis with a novel mevalonate kinase gene mutation: A case report. | World J Clin Cases | 2022 | 35663074 | PubTator, text mining | PubMed |
| Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center. | J Am Heart Assoc | 2022 | 35658515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4598/papers?page=18